Wuxi Biologics (Cayman) Inc. - ADR

Wuxi Biologics (Cayman) Inc. - ADR

WXXWY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$24.52B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Wuxi Biologics (Cayman) Inc. - ADRWuxi Biologics (Cayman) Inc. - ADR32.8-19%0.60.1
$-0.14

Current Fair Value

101.2% downside

Overvalued by 101.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$24.52 Billion
Enterprise Value$21.83 Billion
Earnings per Share$2.38
Beta0.6
Outstanding Shares2,048,323,612

Return

Return on Equity18.99%ROE
Return on Assets13.96%
Return on Invested Capital23.49%

Valuation & Multiples

P/E Ratio32.79P/E Ratio
PEG1041.97PEG
Price to Sales0.57Price to Sales
Price to Book Ratio0.46Price to Book Ratio
Enterprise Value to Revenue0.5
Enterprise Value to EBIT1.62
Enterprise Value to Net Income2
Total Debt to Enterprise0.29
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 26, 2026
EPS Estimate
$0.13
Consensus analyst estimate
Revenue Estimate
$1.70 B
Consensus analyst estimate

Next Earnings Call

Expected Date
March 23, 2027
EPS Estimate
$0.22
Consensus analyst estimate
Revenue Estimate
$2.07 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Wuxi Biologics (Cayman) Inc.

14,705 employees
CEO: Zhisheng Chen

Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale...

Wuxi Biologics (Cayman) Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.